Skip to main content

Because your voice matters.

The Role of Primary Care in the Rollout of COVID 19 Vaccines: A Review of the Canadian Experience

Posted • Last updated

Closed

Commitment: Short-term

Open to Outside BC, Provincial Region, Patient partners working in Ontario, Alberta, Quebec or British Columbia

Last updated

Study topic and purpose:
Ontario’s approach to the rollout of the COVID-19 vaccination strategy started with an initial focus on vaccines being provided through hospitals and then secondarily through mass public health clinics and pharmacies.

Primary care is the first point of contact to the health system, especially for vulnerable and medically underserved communities. When asked where people want to get their COVID vaccines, almost half said their family physician’s office and 87% said they would go to their family physician first for advice on the vaccine itself.  Building vaccine confidence by addressing vaccine hesitancy is a foundational role of primary care as patients trust their primary care providers. Public confidence in vaccine safety and effectiveness and the principles of equity need to be considered in approaches since it can result in unintended consequences of poorer health outcomes, increased COVID burden and less vaccination in underserved and marginalized communities.

Since the delivery of immunizations is part of comprehensive primary care, knowledge users are interested in learning what approaches to the rollout of the vaccines were used in Canada and what lessons can be learned from their experience. Thus, this study will examine the experience of four Canadian jurisdictions (Ontario, Alberta, Quebec, and British Columbia) with the COVID-19 vaccine distribution strategy from the perspective of key informants (i.e., policymakers, public health officials, stakeholders (medical associations, pharmacist associations), healthcare professionals, and patients). This knowledge will help inform a sustainable vaccination strategy for all Ontarians in future COVID-19 vaccination efforts and beyond.

Read more.

Who can participate:
• Individuals aged 18 or older and able to provide informed consent
• Working in Ontario, Alberta, Quebec, or British Columbia
• Policymakers, public health officials and stakeholders involved in the COVID-19 vaccine distribution strategy
• A health care professional involved in the administration of COVID-19 vaccines
• A patient who has received or is contemplating receiving a COVID-19 vaccine

Why:
The purpose of this study is to understand the experience of Canadian jurisdictions with the COVID-19 vaccine distribution strategy

How:
• Participate in a 60-minute interview by phone or virtual technology (Microsoft Teams)
• $25.00 gift card will be provided to patients participating in this study

Impact:
• This study will inform knowledge users in Ontario on the future vaccine strategy for COVID-19 and beyond

Contact information:
To express interest in participating, please contact Dr. Monica Aggarwal at monica.aggarwal@utoronto.ca or the Research Coordinator, Carolynn Warnet at c.warnet@utoronto.ca

From Our Community

Derek Koch

Spiritual Health Practitioner and Patient- and Family-Centred Care Lead — Kelowna General Hospital

Derek Koch

The bottom line is because we’re caring for patients. People who know best are those who are receiving the care so it makes logical sense that we would consult with them about their experiences. By connecting with PVN we have been able to educate our teams about the value of patient partners and how important their perspective is in our services.